Skip to main content

Advertisement

Table 3 Changes over time in the percentage of participants engaging in specific intravaginal practices and in laboratory parameters (vaginal flora, bacterial vaginosis, plasma, genital HIV RNA, IL-6, and IL-8). Plasma and CVL HIV RNA limit of detection was 20 copies/milliliter

From: A bio-behavioral intervention to decrease intravaginal practices and bacterial vaginosis among HIV infected Zambian women, a randomized pilot study

  Baseline (N = 128) N(%) Median(IQR) 6-month (N = 90) N(%) Median(IQR) 12-month (N = 118) N(%) Median(IQR) Baseline vs. 6-month p-value Baseline vs. 12-month p-value 6-month vs. 12-month p-value
Products used for intravaginal practices in the prior month
 Water 91.7% 37.7% 47.2% < 0.001 < 0.001 0.112
 Soap 68.9% 11.8% 36.1% < 0.001 < 0.001 0.001
 Cloth, sponge or a rag 53.4% 6.3% 26.4% < 0.001 < 0.001 0.010
 Traditional medicine 28.5% 3.8% 30.6% 0.001 0.731 < 0.001
 Herbs or flowers from outdoors 18.1% 5.0% 8.8% 0.026 0.070 0.363
 Lemon 9.9% 2.2% 13.7% 0.050 0.034 0.016
 Salt 8.7% 2.2% 6.6% 0.077 0.503 0.172
 Vinegar 2.3% 2.2% 11.8% 0.962 0.017 0.029
Laboratory parameters
 Abnormal vaginal flora 77.3% 60.5% 58.2% 0.014 0.003 0.752
 Bacterial vaginosis 64.2% 15.6% 23.6% < 0.001 < 0.001 0.145
 Detectable plasma HIV RNA 20.8% 14.9% 20.7% 0.147 0.995 0.374
 Detectable CVL HIV RNA 13.8% 8.9% 8.9% 0.314 0.618 0.800
 IL-6 (n = 68) 289.9 (258.0) 328.03 (264.8) -- 0.158 -- --
 IL-8 (n = 68) 332.5 (1781.9) 311.4 (1400.3) -- 0.272 -- --
  1. CVL cervicovaginal lavage
  2. Bold: p < 0.05